Enveda Biosciences

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules.

Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.

Enveda, launched in 2019, is headquartered in Boulder, Colorado.

Enveda Biosciences headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $19.3B in funding across 84 round(s). With a team of 101-250 employees, Enveda Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Enveda Biosciences, raised $55.0M. Discover more about their projects, partnerships, and impact on our platform.